Price
$0.97-12.60%Social Signal Score
Analyst Ratings
27 analystsRevenue
$81.37M+734.42%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Luc Mongeau
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1,128
- Beta
- 2.41
- Country
- CA
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -14.54
Financials
Revenue
$81.37M+734.4%Net Income
$-40.69M-1460.1%EBITDA
$-10.01M-239.4%Free Cash Flow
$-21.56MEPS (diluted)
$-0.10-581.0%Shares Outstanding (diluted)
423.11M+243.9%Operating Expenses
$39.69MCash & Debt
$319.79MRevenue by Segment (annual)
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $284.60M | $-262.91M | $-0.88 |
| 2025 | $269.00M | $-598.12M | $-5.53 |
| 2024 | $297.15M | $-657.27M | $-8.79 |
| 2023 | $333.25M | $-3.28B | $-70.70 |
| 2022 | $475.70M | $-310.04M | $-7.70 |
| 2021 | $546.65M | $-1.74B | $-4.45 |
| 2020 | $398.77M | $-1.32B | $-3.96 |
| 2019 | $226.34M | $-736.28M | $-1.99 |
| 2018 | $77.95M | $-67.28M | $-0.31 |
| 2017 | $39.90M | $-7.52M | $-0.14 |
| 2016 | $12.70M | $-3.50M | $-0.05 |
| 2015 | $1.90M | $-8.93M | $-0.30 |
| 2014 | $0.00 | $-932.9K | $-0.93 |
| 2013 | $4.1K | $-64.6K | $-0.06 |
Valuation
CGChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
60+9.09%Social Signal Score
Mentions (24)
- Newsfool.com·15d ago·Positive
Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors International cannabis net revenue grew 141% year over year to $12.3 million. Cultivation yields have the potential to increase 25% to 30% in the Kincardine facility.
View source ↗ - Newsmarketbeat.com·16d ago·Neutral
Canopy Growth Q2 Earnings Call Highlights Canopy Growth NASDAQ: CGC reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve positive adjusted EBITDA in the second half of fiscal 2027.
View source ↗ - Newszacks.com·16d ago·Negative
Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.01 per share a year ago.
View source ↗ - Newszacks.com·24d ago·Neutral
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - Newszacks.com·26d ago·Positive
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, moving +2.42% from the previous trading session.
View source ↗ - Newsmarketbeat.com·30d ago·Neutral
Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board Canopy Growth NASDAQ: CGC shareholders approved all matters presented at the company's reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election of five directors and the appointment of MNP LLP as auditor for fiscal 2027.
View source ↗ - Newszacks.com·32d ago·Neutral
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors Canopy Growth Corporation (CGC) closed at $0.67 in the latest trading session, marking a -6.67% move from the prior day.
View source ↗ - Newszacks.com·39d ago·Neutral
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market Canopy Growth Corporation (CGC) closed at $0.71 in the latest trading session, marking a -6.27% move from the prior day.
View source ↗ - Newszacks.com·39d ago·Neutral
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - Newsfool.com·43d ago·Positive
Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026? Canopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansion strategy through Canopy USA. Tilray Brands has diversified its revenue stream significantly through a large craft beer and beverage portfolio alongside its global cannabis operations.
View source ↗ - Newszacks.com·46d ago·Neutral
Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today Canopy Growth Corporation (CGC) concluded the recent trading session at $0.87, signifying a -1.87% move from its prior day's close.
View source ↗ - Newszacks.com·52d ago·Negative
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors Canopy Growth Corporation (CGC) reached $0.88 at the closing of the latest trading day, reflecting a -1.54% change compared to its last close.
View source ↗ - Newszacks.com·53d ago·Neutral
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
View source ↗ - Newszacks.com·58d ago·Neutral
Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts Canopy Growth Corporation (CGC) closed at $0.94 in the latest trading session, marking a +1.45% move from the prior day.
View source ↗ - Newszacks.com·60d ago·Neutral
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market Canopy Growth Corporation (CGC) closed the most recent trading day at $0.94, moving 2.34% from the previous trading session.
View source ↗ - Newsfool.com·60d ago·Neutral
Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock? On Sept. 25, Canopy Growth investors will be asked to vote on a reverse stock split. Currently trading below $1, the company could risk being delisted if a reverse split isn't enacted.
View source ↗ - Newszacks.com·66d ago·Positive
Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know In the latest trading session, Canopy Growth Corporation (CGC) closed at $0.94, marking a +2.57% move from the previous day.
View source ↗ - Newszacks.com·67d ago·Neutral
Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
View source ↗ - Newszacks.com·69d ago·Negative
Canopy Growth Corporation (CGC) Advances While Market Declines: Some Information for Investors Canopy Growth Corporation (CGC) reached $0.94 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close.
View source ↗ - Newsbusinesswire.com·69d ago·Neutral
…Ahead of September 23 Deadline SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today reminds shareholders to vote ahead of its Annual General and Special Meeting of shareholders (the “Meeting”) scheduled for Friday, September 25, 2026, at 1:00 p.m. ET. To ensure their votes are counted at the Meeting, shareholders should submit their…
View source ↗ - Newsfool.com·76d ago·Negative
Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Canopy Growth's revenue increased 13% year over year in its most recent fiscal quarter. Adjusted gross margin improved, while EBITDA losses narrowed sharply.
View source ↗ - Newsfool.com·78d ago·Positive
Should You Buy Canopy Growth Stock on the Rebound? Canopy Growth is a large Canadian marijuana company. Over the past year, it has strengthened its financial position and made an acquisition.
View source ↗ - Newsmarijuanastocks.com·82d ago·Neutral
3 Top Marijuana Stocks to Watch in September 2026 The cannabis industry is entering September, and investors are once again searching for opportunities across the sector. After years of volatility, several marijuana companies are showing signs of stronger financial performance. Revenue is improving for some operators. Meanwhile, others are cutting costs, strengthening margins, and expanding internationally. That combination could put marijuana stocks back on investors' radar. However, this is no
View source ↗ - Newsfool.com·106d ago·Negative
Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think The United States is slowly moving toward the legalization of marijuana. The next big step is the rescheduling of the drug at the federal level, which won't make it legal, just less illegal.
View source ↗
Earnings
Typical surprise -161.6% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Nov 6$-0.07 vs $-0.02miss
- Fri, Aug 7$-0.02 vs $-0.04beat
- Mon, Jun 15$-0.29 vs $-0.06miss
- Tue, Mar 31$-0.13 vs $-0.04miss
- Mon, Dec 15$-0.01 vs $-0.11beat
- Fri, Aug 8$-0.22 vs $-0.23beat
Estimates and results for CGC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CGC officers and directors.
- Bought
- $50k
- Sold
- $1.7m
1 trade
54 trades
- Yanofsky Theresasold
- Lazzarato David Angelosold
- Bayern Josephsold
- Atkins M Shansold
- Stewart Thomas Carltonsold
- Gedeon Christellesold
- Stewart Thomas Carltonsold
- Bayern Josephsold
45 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- John Yarmuthhouse · KY03 · disclosed Aug 11, 2021 (519d later)Buy$1,001 - $15,000
- John Yarmuthhouse · KY03 · disclosed Feb 19, 2021 (7d later)Buy$1,001 - $15,000
- John Yarmuthhouse · KY03 · disclosed Nov 15, 2020 (10d later)Buy$1,001 - $15,000
- John Yarmuthhouse · KY03 · disclosed May 2, 2020 (53d later)Sell$1,001 - $15,000
- Brenda L. Lawrencehouse · MI14 · disclosed Aug 21, 2019 (302d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
